Low expression of CHRDL1 and SPARCL1 predicts poor prognosis of lung adenocarcinoma based on comprehensive analysis and immunohistochemical validation

PURPOSE: Exploring the molecular mechanisms of lung adenocarcinoma (LUAD) is beneficial for developing new therapeutic strategies and predicting prognosis. This study was performed to select core genes related to LUAD and to analyze their prognostic value. METHODS: Microarray datasets from the GEO (...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Huan, Hang, Qingqing, Shen, Dijian, Zhang, Yibi, Chen, Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8117659/
https://www.ncbi.nlm.nih.gov/pubmed/33980221
http://dx.doi.org/10.1186/s12935-021-01933-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8117659/
https://www.ncbi.nlm.nih.gov/pubmed/33980221
http://dx.doi.org/10.1186/s12935-021-01933-9

Ejemplares similares